Nutriband inc. issued full patent from the korean intellectual property office for its "abuse and misuse deterrent transdermal system" application

Orlando, fl / accesswire / december 31, 2021 / nutriband inc. (nasdaq:ntrb)(nasdaq:ntrbw), has announced that the korean intellectual property office (kipo) has fully issued its patent titled "abuse and misuse deterrent transdermal system" which is related to the company's lead technology aversa™. the patent underpins 4p therapeutics' abuse deterrent transdermal system, aversa, which uses taste aversion to address the primary routes of abuse for opioid based transdermal patches.
NTRB Ratings Summary
NTRB Quant Ranking